[-] Show simple item record

dc.contributor.authorSaultz, Alishaeng
dc.contributor.authorMathews, Erin Lindsayeng
dc.contributor.authorSaultz, John W.eng
dc.date.issued2010-05eng
dc.description.abstractThere is no evidence to suggest that testing for hypercoagulopathy benefits most patients with deep venous thrombosis (DVT). Nor has research established that thrombophilia test results improve the ability to predict recurrence better than clinical risk assessment alone (strength of recommendation [SOR]: B, multiple cohort studies).eng
dc.identifier.citationJournal of Family Practice, 59(5) 2010: 291+.eng
dc.identifier.urihttp://hdl.handle.net/10355/7717eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofClinical Inquiries, 2010 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectthromboembolismeng
dc.subjectrecurrence riskeng
dc.subject.lcshAnticoagulants (Medicine)eng
dc.subject.lcshThromboembolism -- Treatmenteng
dc.subject.lcshWarfarineng
dc.titleDoes hypercoagulopathy testing benefit patients with DVT?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record